Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:AstraZeneca
gptkb:Alexion_Pharmaceuticals |
| gptkbp:collaboratedWith |
gptkb:Alexion_Pharmaceuticals
|
| gptkbp:focus |
rare diseases
amyloidosis |
| gptkbp:foundedYear |
2017
|
| https://www.w3.org/2000/01/rdf-schema#label |
Caelum Biosciences
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:location |
gptkb:New_York,_United_States
|
| gptkbp:product |
CAEL-101
|
| gptkbp:website |
https://caelumbio.com
|
| gptkbp:bfsParent |
gptkb:Fortress_Biotech
|
| gptkbp:bfsLayer |
7
|